Coronary/Structural Heart

Surgical Theater’s Precision VR® featured during Late-Breaking Science Sessions at the Transcatheter Valve Therapies 2019 Structural Heart Summit

CHICAGO, June 13, 2019 /PRNewswire/ — Leveraging its rich history of providing surgeons and their patients dynamic visualization experiences in the clinic and throughout the treatment continuum, Surgical Theater is proud that the Precision VR® platform is being  featured  at the Transcatheter Valve Therapies (TVT) Structural Heart Summit’s Late-Breaking Science Sessions in Chicago, IL. […]

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite

CHICAGO–(BUSINESS WIRE)–TVT2019 – Structural Heart Summit — Materialise (NASDAQ:MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures. Mimics Enlight is based on the strengths of […]

New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting

CHICAGO, June 13, 2019 /PRNewswire/ — Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 Structural Heart Summit showing increased mitral valve tenting is associated with an improvement in regurgitant volume with the Carillon Mitral Contour […]

Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed’s Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership

TOKYO, June 13, 2019 /PRNewswire/ — Terumo Corporation (TSE: 4543), a leading global medical device manufacturer, today announced that it has secured exclusive global development and commercialization rights to Virtue® Sirolimus-Eluting Balloon (SEB) for percutaneous coronary interventions by entering into a strategic partnership with Orchestra BioMed, Inc., a biomedical innovation company providing high-impact solutions […]

BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery

SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the China National Intellectual Property Administration has recently issued the Company Patent No: ZL 2014 8 00125575 for “Target Site Selection, Entry and Update […]

Transseptal Solutions Announces First Clinical Use of TSP Crosser™ in the United States

NETANYA, Israel, June 12, 2019 /PRNewswire/ — Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation, announced today the completion of the first TSP Crosser™ transseptal puncture procedure in the US. The procedure was successfully performed by Dr. Latib, the New Medical Director of […]

CorMatrix® Cardiovascular, Inc. receives FDA 510(k) clearance to market the Cor™ PATCH epicardial patch for tissue support and repair in adult patients

ATLANTA, June 11, 2019 /PRNewswire/ — CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced FDA 510(k) clearance for the Cor™ PATCH.  The Cor™ PATCH is indicated for epicardial tissue support and repair in adult patients. The Cor™ PATCH epicardial patch is the first epicardial cardiovascular medical device composed of first next […]

Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the launch of and first patient prescription for the ZOLL µCor™ (pronounced “Micro Core”) Heart Failure and Arrhythmia Management System (HFAMS), designed to help clinicians improve outcomes and reduce hospitalizations for […]

Precision Wellness Validates Performance of Predictive Risk Models to Power Precision Health

PALO ALTO, Calif.–(BUSINESS WIRE)–Precision Wellness, Inc. a Silicon Valley-based company at the intersection of next-generation AI, big data analytics and the latest medical science, today announced the validation of its cardiometabolic disease (CMD) predictive risk engine. The study was performed as part of a sponsored research with Stanford University to evaluate 416,936 […]

Itamar Medical’s WatchPAT™ One, the First and Only Fully Disposable Home Sleep Apnea Test Receives FDA 510(k) Clearance

New system expands WatchPAT access to additional sleep centers by reducing infrastructure needs and eliminating capital requirements; also reduces infection risk for in-patient sleep apnea testing  CAESAREA, Israel, June 06, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq:ITMR) (TASE:ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices […]